Interested in more news from CMIT? Sign up for our newsletter.
-
Spotlight on Dr. Duane Wesemann, MD, PhD
Interview with Dr. Duane Wesemann, an Assistant Professor at Harvard Medical School, and a Principal investigator in the Division of Rheumatology, Immunology and Allergy at the Brigham and Women’s Hospital.
-
Framework for Rational Donor Selection in Fecal Microbiota Transplant Clinical Trials
Fecal Microbiota Transplant (FMT) is gaining traction as a potentially effect treatment of the increasing number of diseases that have been linked to microbiome dysbiosis.
-
Mapping Human Microbiome Drug Metabolism by Gut Bacteria and Their Genes
In a recent study published in Nature by Zimmerman (et.al), researchers begin to uncover how intestinal bacteria chemically modify prescription drugs.
-
Spotlight on Brittany Berdy, PhD
This month I interviewed Brittany Berdy, PhD, who is CMIT’s pinpoint person for their Bio-Microbial Library Strain Collection.
-
Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort
To look for associations between the gut microbiome composition and development of Type 2 Diabetes, CMIT collaborated with researchers at institutes and hospitals within Mexico to study a cohort that had not been been diagnosed with, or treated for T2D, avoiding the potential influences of medication and lifestyle changes on gut microbes.
-
CMIT Annual Request for Applications is Open
The Center for Microbiome Informatics and Therapeutics was founded to accelerate the development of therapeutics to treat microbiome-associated disease, with a core focus on Inflammatory Bowel Disease (IBD).
-
Going for the Gut
Working to preserve human microbiome diversity
-
Multi-omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases
In a recently published paper in Nature, Lloyd-Price (et.al) provide a comprehensive analysis of the longitudinal variation in the gut microbiome of patients with IBD.
-
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
CMIT is collaborating with Dr. Patricia Pringle and Dr. Raymond Chung from Massachusetts General Hospital (MGH) on a new study that is investigating the potential role of fecal microbiota transplantation (FMT) as a treatment for hepatic encephalopathy.
-
An Interview with Dr. Jessica R. Allegretti, MD, MPH
Dr. Jessica Allegretti is an inspiring example of a clinician who works passionately to improve the lives of those suffering from Inflammatory Bowel Disease (IBD).